Viridian Therapeutics, Inc.\DE (VRDN) Change in Receivables (2013 - 2020)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Change in Receivables came in at -$48000.0 in Q4 2020, up 74.87% quarter-over-quarter from -$191000.0 in Q3 2020.
Viridian Therapeutics, Inc.\DE (VRDN) Change in Receivables (2013 - 2020) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Change in Receivables history runs 8 years deep, the most recent figure standing at -$48000.0 for Q4 2020.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to -$48000.0 in Q4 2020; TTM through Dec 2020 was -$99000.0, a N/A change from a year earlier, with the FY2020 full-year figure at -$99000.0, down 217.86% from the prior year.
- Change in Receivables advanced to -$48000.0 in Q4 2020 per VRDN's latest filing, from -$191000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $3.4 million in Q1 2018 and bottomed at -$3.6 million in Q2 2018.
- The 5-year median for Change in Receivables is $96000.0 (2017), against an average of $61210.5.
- Across the five-year window, Change in Receivables slumped 2044.12% in 2016 and surged 7363.64% in 2017, its largest moves.
- Year by year, Change in Receivables stood at $11000.0 in 2016, then jumped by 7363.64% to $821000.0 in 2017, then plunged by 265.41% to -$1.4 million in 2018, then soared by 170.32% to $955000.0 in 2019, then tumbled by 105.03% to -$48000.0 in 2020.
- Per Business Quant, the three latest VRDN Change in Receivables figures stand at -$48000.0 (Q4 2020), -$191000.0 (Q3 2020), and $244000.0 (Q2 2020).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 229.55 Mn | 229.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -48,000.00 |
| Dec 31, 2020 | -48,000.00 |
| Sep 30, 2020 | -191,000.00 |
| Sep 30, 2020 | -191,000.00 |
| Jun 30, 2020 | 244,000.00 |
| Jun 30, 2020 | 244,000.00 |
| Mar 31, 2020 | -104,000.00 |
| Mar 31, 2020 | -104,000.00 |
| Sep 30, 2019 | 955,000.00 |
| Sep 30, 2019 | 955,000.00 |
| Jun 30, 2019 | 301,000.00 |
| Jun 30, 2019 | 301,000.00 |
| Mar 31, 2019 | -18,000.00 |
| Mar 31, 2019 | -18,000.00 |
| Dec 31, 2018 | -1.36 Mn |
| Dec 31, 2018 | -1.36 Mn |
| Sep 30, 2018 | 184,000.00 |
| Sep 30, 2018 | 184,000.00 |
| Jun 30, 2018 | -3.61 Mn |
| Jun 30, 2018 | -3.61 Mn |